JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $1 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 48.9% | -17.8% | 0.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.2% | 47% | 50.4% | 50.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -75.3% | -260.7% | -236% | -261.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -251.3% | -490.7% | -276.8% | -450.1% |
| EPS Diluted | -0.64 | -0.84 | -0.58 | -0.94 |
| % Growth | 23.8% | -44.8% | 38.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |